» Articles » PMID: 19166889

Micro- and Macrorheology of Mucus

Overview
Specialty Pharmacology
Date 2009 Jan 27
PMID 19166889
Citations 349
Authors
Affiliations
Soon will be listed here.
Abstract

Mucus is a complex biological material that lubricates and protects the human lungs, gastrointestinal (GI) tract, vagina, eyes, and other moist mucosal surfaces. Mucus serves as a physical barrier against foreign particles, including toxins, pathogens, and environmental ultrafine particles, while allowing rapid passage of selected gases, ions, nutrients, and many proteins. Its selective barrier properties are precisely regulated at the biochemical level across vastly different length scales. At the macroscale, mucus behaves as a non-Newtonian gel, distinguished from classical solids and liquids by its response to shear rate and shear stress, while, at the nanoscale, it behaves as a low viscosity fluid. Advances in the rheological characterization of mucus from the macroscopic to nanoscopic levels have contributed critical understanding to mucus physiology, disease pathology, and the development of drug delivery systems designed for use at mucosal surfaces. This article reviews the biochemistry that governs mucus rheology, the macro- and microrheology of human and laboratory animal mucus, rheological techniques applied to mucus, and the importance of an improved understanding of the physical properties of mucus to advancing the field of drug and gene delivery.

Citing Articles

Structure and function relationships of mucociliary clearance in human and rat airways.

Roth D, Sahin A, Ling F, Tepho N, Senger C, Quiroz E Nat Commun. 2025; 16(1):2446.

PMID: 40069153 PMC: 11897160. DOI: 10.1038/s41467-025-57667-z.


Photo-regulated disulfide crosslinking: a versatile approach to construct mucus-inspired hydrogels.

Chen R, Das K, Feng J, Thongrom B, Haag R Chem Sci. 2025; .

PMID: 40012688 PMC: 11851172. DOI: 10.1039/d4sc08284b.


Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.

Jiao Q, Huang Y, He J, Xu Y Pharmaceutics. 2025; 17(2).

PMID: 40006605 PMC: 11859201. DOI: 10.3390/pharmaceutics17020238.


Sensing Mucus Physiological Property In Situ by Wireless Millimeter-Scale Soft Robots.

Xiao B, Xu Y, Edwards S, Balakumar L, Dong X Adv Funct Mater. 2025; 34(8).

PMID: 39990597 PMC: 11845219. DOI: 10.1002/adfm.202307751.


Wirelessly Actuated Ciliary Airway Stent for Excessive Mucus Transportation.

Wang Y, Sharma S, Maldonado F, Dong X Adv Mater Technol. 2025; 8(23).

PMID: 39949354 PMC: 11823681. DOI: 10.1002/admt.202301003.


References
1.
Sheils C, Kas J, Travassos W, Allen P, Janmey P, Wohl M . Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol. 1996; 148(3):919-27. PMC: 1861734. View

2.
Shak S . Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest. 1995; 107(2 Suppl):65S-70S. DOI: 10.1378/chest.107.2_supplement.65s. View

3.
Carlstedt I, Sheehan J . Structure and macromolecular properties of cervical mucus glycoproteins. Symp Soc Exp Biol. 1989; 43:289-316. View

4.
Konstan M, Hilliard K, Norvell T, Berger M . Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med. 1994; 150(2):448-54. DOI: 10.1164/ajrccm.150.2.8049828. View

5.
Bell A, Sellers L, Allen A, Cunliffe W, Morris E . Properties of gastric and duodenal mucus: effect of proteolysis, disulfide reduction, bile, acid, ethanol, and hypertonicity on mucus gel structure. Gastroenterology. 1985; 88(1 Pt 2):269-80. DOI: 10.1016/s0016-5085(85)80180-3. View